- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04096274
Working to Implement and Sustain Digital Outcome Measures (WISDOM)
Randomized Trial of a Leadership and Organizational Change Strategy to Improve the Implementation and Sustainment of Digital Measurement-based Care in Youth Mental Health Services
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Diego, California, United States, 92093
- University of California, San Diego
-
-
Florida
-
Orlando, Florida, United States, 32816
- University of Central Florida
-
-
Idaho
-
Boise, Idaho, United States, 83725
- Boise State University
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Participants for this project will fall into four groups: 1) clinic executives and upper leaders (i.e., Chief Executive Officer, Executive Directors, program administrators, n=20), 2) clinic first-level leaders (i.e. clinical supervisors, n=20), 3) clinicians serving children with emotional and behavioral disorders (n=120), and 4) caregivers of children with emotional and behavioral disorders who receive outpatient mental health services within participating clinics (n=720). Caregivers will be recruited in two distinct cohorts of 360 each.
Inclusion criteria for all groups of participants are intentionally broad in line with the pragmatic nature of the trial.
Inclusion Criteria for Clinics
- Provide outpatient psychotherapy services to children ages 4 to 18 who have emotional and/ or behavioral disorders and their families
- Have at least 3 full time equivalent clinicians on staff
- Not currently implementing a digital measurement-based care system clinic wide
Inclusion Criteria for Executives and Upper Leaders
1. Identified as Chief Executive Officer, Executive Director, or high-level administrator at an enrolled clinic
Inclusion Criteria for first-level leaders
1. Identified as a clinical supervisor or clinical work-group supervisor/ leader at an enrolled clinic
Inclusion Criteria for Clinicians
- Employed as staff at participating clinic
- Provides outpatient mental health services (psychotherapy) to youth clients
Inclusion Criteria for Caregivers of Youth Who Receive Services at Participating Clinics
- Child is ages 4 to 18 years at intake,
- Child has been diagnosed with an emotional or behavioral disorder by clinic staff
- Clinical staff at the site determined that the youth's treatment needs can be appropriately addressed by the clinic
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: LOCI (Intervention)
In clinics assigned to the LOCI condition, executives and first-level leaders will receive leadership training and coaching to support implementation of the OQ-A system.
In addition, leaders and clinicians in this condition will receive training and technical assistance to implement the OQ-A measurement-based care system.
|
LOCI is a multicomponent implementation strategy that engages organizational executives and first-level leaders (i.e., those who administratively supervise clinicians) to build an organizational climate to support the implementation of a focal evidence-based practice (EBP) with fidelity.
In this study, the focal EBP is the OQ-A system.
LOCI includes two overarching components: (1) monthly organizational strategy meetings between executives and LOCI consultants/trainers to develop and embed policies, procedures, and practices that support implementation of a focal EBP, and (2) training and coaching for first-level leaders, to develop their skills in leading implementation.
The aim of these components is to develop an organizational implementation climate in which clinicians' perceive that use of the OQ-A with high fidelity is expected, supported, and rewarded.
All leaders and clinicians in participating clinics will receive standardized OQ-A training and technical assistance provided by the OQ-A purveyor organization. This includes an initial, 6-hr, in-person OQ-A training; two, live, virtual, 1-hr booster trainings, offered 3 and 5 months after the initial training; and, year-round technical assistance from the OQ-A purveyor organization. Technical assistance includes virtual training sessions, online library of training videos, and customer care representative for technical support. In addition, to encourage participation in the study, a set of four 1-hr, web-based general leadership seminars will be offered to leaders in the control condition. These will cover topics ranging from effective leadership, to giving effective feedback. |
|
Active Comparator: Training and Technical Assistance only (Control)
In clinics assigned to the control group, leaders and clinicians will receive training and technical assistance to implement the OQ-A measurement-based care system.
In addition, to support enrollment in this condition, leaders in this condition will be offered access to general web-based leadership seminars.
|
All leaders and clinicians in participating clinics will receive standardized OQ-A training and technical assistance provided by the OQ-A purveyor organization. This includes an initial, 6-hr, in-person OQ-A training; two, live, virtual, 1-hr booster trainings, offered 3 and 5 months after the initial training; and, year-round technical assistance from the OQ-A purveyor organization. Technical assistance includes virtual training sessions, online library of training videos, and customer care representative for technical support. In addition, to encourage participation in the study, a set of four 1-hr, web-based general leadership seminars will be offered to leaders in the control condition. These will cover topics ranging from effective leadership, to giving effective feedback. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage Fidelity to the OQ-A System Experienced by the Youth (0-100%)
Time Frame: 0-6 months after youth's baseline/ entry into treatment
|
Fidelity to the OQ-A will be measured by using electronic meta-data from the OQ-A system combined with caregiver reported information on the number of sessions the youth attended.
For each youth, a fidelity index will be generated that represents the product of two quantities: (a) the youth's completion rate (i.e., number of measures administered relative to the number of sessions attended within the 6-month observation period), and (b) the youth's viewing rate (i.e., the number of feedback reports viewed by the clinician relative to the number of measures administered).
Note that this product is equivalent to the ratio of viewed feedback reports to total sessions; it represents an events/trials proportion.
MBC fidelity index scores summarize the level of MBC fidelity experienced by each youth (range=0-1).
Higher scores indicate the youth experienced greater fidelity to MBC.
|
0-6 months after youth's baseline/ entry into treatment
|
|
Change From Baseline to 6-months in Youth Total Problems Score on the Short Form Assessment for Children (SAC) - Phase I Cohort
Time Frame: 0-6 months after youth's baseline/ entry into treatment
|
The SAC Total Problem Score is a 48-item measure of youth internalizing (e.g., anxious, depressed) and externalizing (e.g., aggressive, noncompliant, overactive) behaviors (range=0-96) completed by caregivers of youth.
Total Problem Score was assessed at baseline (youth's entry into treatment) and monthly for 6 months, change from baseline to month 6 is reported.
|
0-6 months after youth's baseline/ entry into treatment
|
|
Change From Baseline to 6-months in Youth Total Problems Score on the Short-form Assessment for Children (SAC) - Phase II Cohort
Time Frame: 0-6 months after youth's baseline/ entry into treatment
|
The SAC Total Problem Score is a 48-item measure of youth internalizing (e.g., anxious, depressed) and externalizing (e.g., aggressive, noncompliant, overactive) behaviors (range=0-96) completed by caregivers of youth.
Total Problem Score was assessed at baseline (youth's entry into treatment) and monthly for 6 months, change from baseline to month 6 is reported.
|
0-6 months after youth's baseline/ entry into treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline in First-level Leaders' Implementation Leadership (ILS)
Time Frame: 0-18 months
|
Clinicians will assess the extent to which their first-level leaders (e.g., clinical program manager) exhibit implementation leadership behaviors with regard to the OQ-A using the 12-item Implementation Leadership Scale (ILS).
Responses are made on a 0 (not at all) to 4 (very great extent) scale.
Total scores are calculated as the mean of all items.
Higher scores indicate more extensive demonstration of implementation leadership behaviors.
This outcome will be assessed at baseline, 4-, 8-, 12-, and 18-months.
Clinician responses will be aggregated to the clinic level as appropriate.
|
0-18 months
|
|
Change from Baseline in First-level Leaders' Transformational Leadership (MLQ)
Time Frame: 0-18 months
|
Clinicians will assess the extent to which their first-level leaders exhibit transformational leadership behaviors using the Multifactor Leadership Questionnaire (MLQ).
Responses are made on a 5-point scale ("Not at all" to "Frequently, if not always").
Consistent with prior studies, we will use the 20-item transformational leadership total score, calculated as the mean of four subscales: idealized influence, inspirational motivation, intellectual stimulation, and individual consideration.
This outcome will be assessed at baseline, 4-, 8-, 12-, and 18-months.
Clinician responses will be aggregated to the clinic level as appropriate.
|
0-18 months
|
|
Change from Baseline in Clinic Implementation Climate for OQ-A
Time Frame: 0-18 months
|
Clinicians' perceptions of their clinics' implementation climate for OQ-A will be measured using the 18-item Implementation Climate Scale (ICS).
Responses are made on a 0 (Not at All) to 4 (A Very Great Extent) scale with the total score calculated as the mean of all items.
Higher scores indicate higher levels of implementation climate for OQ-A.
This outcome will be assessed at baseline, 4-, 8-, 12-, and 18-months.
Clinician responses will be aggregated to the clinic level as appropriate.
|
0-18 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nate Williams, PhD, Boise State University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 8424 (Fred Hutch/University of Washington Cancer Consortium)
- R01MH119127 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Behavioral Symptoms
-
AccareRecruitingBehavioral Problem of Child | Behavioral DifficultiesNetherlands
-
University of MinnesotaRecruiting
-
University of AarhusInnovation Fund Denmark; TRYG Foundation; The Danish Mental Health Foundation; Aarhus...CompletedDepressive Symptoms | Anxiety Symptoms | Behavioral Problem | School AbsenteeismDenmark
-
Universidad de los Andes, ChileUniversity of TalcaRecruitingBehavioral Problem of ChildChile
-
Universidade do PortoCentro Hospitalar Universitário de São João, E.P.E.; Centro de Investigação... and other collaboratorsCompletedAnxiety | Behavioral Problem of ChildPortugal
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Active, not recruiting
-
University of Colorado, DenverNational Institute of Mental Health (NIMH); National Institutes of Health (NIH)RecruitingStress | Parenting | Irritable Mood | Behavioral ProblemUnited States
-
Central Hospital, Nancy, FranceMarie MANGEOT- Nurse; Mahmut GUNDESLI MDCompleted
-
Fatima Jinnah Women UniversityRecruitingWell-being, Emotional and Behavioral Problems, AdolescentsPakistan
-
AccareRecruitingBrief Parent Training for Children With Behavioral Difficulties in Primary Care Settings (PAINT-POH)Behavioral DifficultiesNetherlands
Clinical Trials on Leadership for Organization Change and Implementation (LOCI)
-
University of California, San DiegoUniversity of Central Florida; Pacific Institute for Research and Evaluation; Chestnut Health SystemsCompletedExperimental | ControlUnited States
-
Jaakko VarpulaRecruitingLeadership | Malnutrition Elderly | Self-HarmFinland
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)RecruitingDepression | AnxietyMalawi
-
University of PittsburghNational Institute of Mental Health (NIMH); University of Michigan; NYU Langone... and other collaboratorsRecruitingAttention Deficit and Disruptive Behavior Disorders | Child Behavior ProblemUnited States
-
Mayo ClinicCompletedAlzheimer Disease | Cognitive Symptom | Pre Senile DementiaUnited States
-
University of Massachusetts, AmherstUniversity of Maryland, Baltimore; Yale University; National Institute on Aging... and other collaboratorsCompletedDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Dementia, Mild | Dementia Moderate | Dementia FrontalUnited States
-
Charles Drew University of Medicine and ScienceNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Palo Alto Veterans Institute for ResearchUnited States Department of DefenseCompletedPosttraumatic Stress DisorderUnited States
-
Kairon Connect, PBCRecruiting
-
Barbara Ann Karmanos Cancer InstituteRecruitingCancer | Neuroendocrine Tumors | Cancer Survivors | Gastrointestinal Cancers | Multiple Myeloma, NeoplasmsUnited States